Xlife Sciences AG
SIX:XLS

Watchlist Manager
Xlife Sciences AG Logo
Xlife Sciences AG
SIX:XLS
Watchlist
Price: 29.1 CHF 0.69% Market Closed
Market Cap: 167.1m CHF
Have any thoughts about
Xlife Sciences AG?
Write Note

Xlife Sciences AG
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Xlife Sciences AG
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Xlife Sciences AG
SIX:XLS
Current Portion of Long-Term Debt
CHf950.6k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Current Portion of Long-Term Debt
CHf146k
CAGR 3-Years
-90%
CAGR 5-Years
-69%
CAGR 10-Years
-42%
Siegfried Holding AG
SIX:SFZN
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Current Portion of Long-Term Debt
CHf191m
CAGR 3-Years
-39%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Tecan Group AG
SIX:TECN
Current Portion of Long-Term Debt
CHf11.5m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Current Portion of Long-Term Debt
CHf870k
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
No Stocks Found

Xlife Sciences AG
Glance View

Market Cap
166m CHF
Industry
Life Sciences Tools & Services

Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company is headquartered in Zurich, Zuerich and currently employs 19 full-time employees. The company went IPO on 2019-09-30. The firm focuses on investing in technologies in the life science industry. The company supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The firm offers its investors direct access to the further development of technologies at a very early stage. The firm cooperates with industrial partners and universities.

XLS Intrinsic Value
1.37 CHF
Overvaluation 95%
Intrinsic Value
Price

See Also

What is Xlife Sciences AG's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
950.6k CHF

Based on the financial report for Dec 31, 2023, Xlife Sciences AG's Current Portion of Long-Term Debt amounts to 950.6k CHF.

What is Xlife Sciences AG's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 1Y
773%

Over the last year, the Current Portion of Long-Term Debt growth was 773%.

Back to Top